may 23, 2017 - Pembrolizumab Approved
Description:
FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.
Added to timeline:
Date:
~ 8 years and 4 months ago